Healthcare resource utilization and costs in 23–25-year-old women with human papillomavirus (HPV) associated anogenital diseases in Germany – a retrospective analysis of statutory health insurance claims data

Table 5 Healthcare costs (€) for 23–25-year-old women during 3-year observation period

	Total costs		Outpatient care		Inpatient care		Pharmaceutical costs
	Cases	Controls	Cases	Controls	Cases	Controls	Cases	Controls
Mean	4,119	3,030	1,714	1,266	1,646	1,220	759	544
SD	8,906	9,256	1,394	1,383	4,970	4,910	5,459	6,732
Min	130	0	76	0	0	0	0	0
Q1	1,089	665	907	584	0	0	44	26
Median	1,883	1,199	1,336	940	0	0	100	70
Q3	4,292	3,086	2,025	1,538	1,762	681	212	165
Max	167,999	688,293	14,182	86,056	107,171	306,853	123,006	680,668

Costs are displayed in Euros (€). Descriptive statistics are based on 2,972 cases and 29,720 controls
Abbreviations: SD Standard deviation, Min Minimum, Q1 25^th percentile, Q3 75^th percentile, Max Maximum

ISSN: 1472-6963